Methodist Healthcare System of San Antonio Internal Medicine

Topics

• Inflammatory Bowel Disease 12
• Mechanical Circulatory Support Devices 10
• Radiomics and Machine Learning in Medical Imaging 10
• Coronary Interventions and Diagnostics 7
• Liver Disease Diagnosis and Treatment 6
• Cardiac Imaging and Diagnostics 4
• Cardiovascular Health and Risk Factors 4
• Respiratory Support and Mechanisms 4
• Chronic Obstructive Pulmonary Disease (COPD) Research 3
• Cystic Fibrosis Research Advances 3
• Thyroid Cancer Diagnosis and Treatment 3
• Cardiac Arrest and Resuscitation 2

Most cited

1. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.

   The New England journal of medicine · 2024 · 1,637 citations · Madhavi Rudraraju

2. Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.

   The New England journal of medicine · 2025 · 102 citations · Madhavi Rudraraju

3. Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial.

   The lancet. Gastroenterology & hepatology · 2024 · 89 citations · Madhavi Rudraraju

4. Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial.

   The Lancet. Respiratory medicine · 2026 · 17 citations · Jeffrey Dellavolpe

5. Ischemia with no obstructive coronary artery disease (INOCA): A patient self-report quality of life survey from INOCA international.

   International journal of cardiology · 2023 · 79 citations · Najah Khan

6. Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease.

   Crohn's & colitis 360 · 2022 · 82 citations · Kerri Glassner